
Celeste A. Roney
Examiner (ID: 19047, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 873 |
| Issued Applications | 472 |
| Pending Applications | 148 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17944211
[patent_doc_number] => 20220331228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/620946
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620946 | ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT | Jun 16, 2020 | Pending |
Array
(
[id] => 16511544
[patent_doc_number] => 20200390801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => LEAVE-ON ORAL CARE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/899919
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899919 | Leave-on oral care compositions | Jun 11, 2020 | Issued |
Array
(
[id] => 16326634
[patent_doc_number] => 20200297599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => MOISTURIZING ANHYDROUS BUTTER BALM COMPOSITION AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/895968
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895968
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895968 | Moisturizing anhydrous butter balm composition and method | Jun 7, 2020 | Issued |
Array
(
[id] => 17759842
[patent_doc_number] => 20220233454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => TUNABLE DEGRADATION IN HYDROGEL MICROPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/617086
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18528
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617086 | Tunable degradation in hydrogel microparticles | Jun 4, 2020 | Issued |
Array
(
[id] => 16310675
[patent_doc_number] => 20200289413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF DISORDERS OF THE ORAL CAVITY, UPPER AIRWAYS AND ESOPHAGUS
[patent_app_type] => utility
[patent_app_number] => 16/884245
[patent_app_country] => US
[patent_app_date] => 2020-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2472
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16884245
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/884245 | COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF DISORDERS OF THE ORAL CAVITY, UPPER AIRWAYS AND ESOPHAGUS | May 26, 2020 | Abandoned |
Array
(
[id] => 16282599
[patent_doc_number] => 20200276201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => MODULATION OF THE NITRIC OXIDE SYNTHASE PATHWAY FOR ORAL HEALTH
[patent_app_type] => utility
[patent_app_number] => 16/876181
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876181
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876181 | MODULATION OF THE NITRIC OXIDE SYNTHASE PATHWAY FOR ORAL HEALTH | May 17, 2020 | Abandoned |
Array
(
[id] => 17733054
[patent_doc_number] => 20220218513
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => INSTRINSICALLY LUBRICATING DRUG-LOADED HYDROGELS FOR USE AS PROPHYLACTIC MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/610334
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3797
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610334
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610334 | INSTRINSICALLY LUBRICATING DRUG-LOADED HYDROGELS FOR USE AS PROPHYLACTIC MEDICAL DEVICES | May 13, 2020 | Pending |
Array
(
[id] => 17212956
[patent_doc_number] => 20210346292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Pharmaceutical preparation for increasing stability and bioavailability of Botulinum toxin A and its complex
[patent_app_type] => utility
[patent_app_number] => 16/867693
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2769
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16867693
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/867693 | Pharmaceutical preparation for increasing stability and bioavailability of Botulinum toxin A and its complex | May 5, 2020 | Abandoned |
Array
(
[id] => 18477079
[patent_doc_number] => 11690803
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Tumor pH-shiftable coating and the nucleus-directed nanoparticles facilitate the targeted chemotherapy and gene therapy against multiple cancers and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/858261
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 76
[patent_no_of_words] => 8059
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858261 | Tumor pH-shiftable coating and the nucleus-directed nanoparticles facilitate the targeted chemotherapy and gene therapy against multiple cancers and use thereof | Apr 23, 2020 | Issued |
Array
(
[id] => 16204678
[patent_doc_number] => 20200237668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PREPARATION OF DESICCATED LIPOSOMES FOR USE IN COMPRESSIBLE DELIVERY SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/846975
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7895
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846975
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846975 | Preparation of desiccated liposomes for use in compressible delivery systems | Apr 12, 2020 | Issued |
Array
(
[id] => 16375119
[patent_doc_number] => 20200323961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => LIPID-BASED NANOPARTICLES AND USE OF SAME IN OPTIMIZED INSULIN DOSING REGIMENS
[patent_app_type] => utility
[patent_app_number] => 16/846101
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 198
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16846101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/846101 | Lipid-based nanoparticles and use of same in optimized insulin dosing regimens | Apr 9, 2020 | Issued |
Array
(
[id] => 16326669
[patent_doc_number] => 20200297634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => METHOD OF MAKING LIPID-ENCAPSULATED RNA NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 16/823212
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823212 | Method of making lipid-encapsulated RNA nanoparticles | Mar 17, 2020 | Issued |
Array
(
[id] => 17058890
[patent_doc_number] => 11103471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Antimicrobials and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/822859
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 53
[patent_no_of_words] => 23484
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16822859
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/822859 | Antimicrobials and methods of use thereof | Mar 17, 2020 | Issued |
Array
(
[id] => 17640728
[patent_doc_number] => 20220168466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => COATING COMPRISING ANTI-MICROBIAL PARTICLES, METHODS OF PREPARATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/434203
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434203
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/434203 | COATING COMPRISING ANTI-MICROBIAL PARTICLES, METHODS OF PREPARATION AND USES THEREOF | Feb 26, 2020 | Pending |
Array
(
[id] => 17593689
[patent_doc_number] => 20220143262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => ANTIBACTERIAL WOUND TREATMENTS WITH CLOT-PROMOTING PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/433731
[patent_app_country] => US
[patent_app_date] => 2020-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433731 | Antibacterial wound treatments with clot-promoting properties | Feb 24, 2020 | Issued |
Array
(
[id] => 17546821
[patent_doc_number] => 20220118162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => BIODEGRADABLE MEMBRANE
[patent_app_type] => utility
[patent_app_number] => 17/427999
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427999 | BIODEGRADABLE MEMBRANE | Feb 4, 2020 | Abandoned |
Array
(
[id] => 16204823
[patent_doc_number] => 20200237813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => INHIBITION OF UCHL1 IN HIGH-GRADE SEROUS OVARIAN CANCER
[patent_app_type] => utility
[patent_app_number] => 16/774460
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774460 | Inhibition of UCHL1 in high-grade serous ovarian cancer | Jan 27, 2020 | Issued |
Array
(
[id] => 17546591
[patent_doc_number] => 20220117932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => Lecithin Vesicles
[patent_app_type] => utility
[patent_app_number] => 17/425149
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17425149
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/425149 | Lecithin vesicles | Jan 23, 2020 | Issued |
Array
(
[id] => 16204720
[patent_doc_number] => 20200237710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/750952
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750952 | SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER | Jan 22, 2020 | Abandoned |
Array
(
[id] => 18860360
[patent_doc_number] => 20230414794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => PSMA INHIBITOR, COMPOUND AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 18/019758
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019758
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/019758 | PSMA INHIBITOR, COMPOUND AND APPLICATION | Jan 20, 2020 | Pending |